Novocure (NVCR) Tops Q3 EPS by 9c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $167 million versus the consensus estimate of $158.54 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alan Greenspan, influential former Federal Reserve chair, dies at 100
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer